Literature DB >> 9350913

Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempos de Espera.

J Marrugat1, G Sanz, R Masiá, V Valle, L Molina, M Cardona, J Sala, L Serés, L Szescielinski, X Albert, J Lupón, J Alonso.   

Abstract

OBJECTIVES: The aim of the present study was to ascertain whether the degree of accessibility to coronary angiography and revascularization results in differing usages or outcomes, or both, in the setting of a high coverage national health system.
BACKGROUND: The selective use of coronary angiography and revascularization procedures in the management of acute myocardial infarction (MI) remains controversial.
METHODS: A cohort of 1,460 consecutive patients with a first MI admitted to four referral teaching hospitals (one with tertiary facilities) were followed up for 6 months after admission. Only patients initially admitted to each of the study hospitals were retained for analysis in the original hospital's cohort. End points were 6-month mortality and readmission for reinfarction, unstable angina, heart failure or severe ventricular arrhythmia.
RESULTS: Patients admitted to the tertiary hospital were more likely to undergo coronary angiography (adjusted relative risk 4.22, 95% confidence interval [CI] 3.37 to 5.45) than those admitted to the nontertiary sites (use rate: 22.1% for nontertiary care, 55.5% for tertiary care). Revascularization procedures were performed in 21.2% of patients in the tertiary hospital and in 8.3% in the nontertiary hospitals (p < 0.0001). Median delay for emergency coronary angiography was shorter in the tertiary hospital (within 1 vs. 2 days, p < 0.0001). Six-month mortality or readmission rates were similar (23.7% and 24.7% for tertiary and nontertiary care, respectively). After adjustment for comorbidity and disease severity, the relative risk of death or readmission for the tertiary hospital was 1.03 (95% CI 0.69 to 1.53) times that of the nontertiary hospitals.
CONCLUSIONS: Selective use of coronary angiography and revascularization procedures may be as effective as less restricted use in the management of acute MI.

Entities:  

Mesh:

Year:  1997        PMID: 9350913     DOI: 10.1016/s0735-1097(97)00312-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  APACHE-II score and Killip class for patients with acute myocardial infarction.

Authors:  Juan Mercado-Martínez; Ricardo Rivera-Fernández; Eduardo Aguilar-Alonso; Angel García-Alcántara; Andrés Estivill-Torrull; Agustín Aranda-León; María Consuelo Guia-Rambla; Mari Paz Fuset-Cabanes
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

2.  The VANQWISH Trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction.

Authors:  G A Beller; K A Brown
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

3.  Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome.

Authors:  Max Brosa; Carlos Rubio-Terrés; Ibrahim Farr; Vijay Nadipelli; Jenaro Froufe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Association of time elapsed since the last coronary event with health services utilization.

Authors:  Miguel-Angel Munoz; Josep-María Manresa; Josep Espinasa; Jaume Marrugat
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT.

Authors:  J Candell-Riera; J Llevadot; C Santana; J Castell; S Aguadé; L Armadans; B Bermejo; G Oller; H García-del-Castillo; M Soler-Peter; J Soler-Soler
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

6.  Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study.

Authors:  Frans Van de Werf; Joel M Gore; Alvaro Avezum; Dietrich C Gulba; Shaun G Goodman; Andrzej Budaj; David Brieger; Kami White; Keith A A Fox; Kim A Eagle; Brian M Kennelly
Journal:  BMJ       Date:  2005-01-21

7.  Impact of selected geographical and clinical conditions on thrombolysis rate in myocardial infarction in three departments of France.

Authors:  M Rabilloud; D Cao; B Riche; F Delahaye; R Ecochard
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Measuring comorbidity in cardiovascular research: a systematic review.

Authors:  Harleah G Buck; Jabar A Akbar; Sarah Jingying Zhang; Janet A Prvu Bettger
Journal:  Nurs Res Pract       Date:  2013-07-17

9.  Access to myocardial revascularization procedures: closing the gap with time?

Authors:  Alain Vanasse; Théophile Niyonsenga; Josiane Courteau; Abbas Hemiari
Journal:  BMC Public Health       Date:  2006-03-08       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.